DANA SWEITZER: Open Payments
NPI 1104259324 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 84 payments from 22 companies in 2025. Trend: 2023 $1,352 · 2024 $1,260 · 2025 $1,488
Food & beverage: $1,474Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $320 |
| ABBVIE INC. | 12 | $247 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $185 |
| AstraZeneca Pharmaceuticals LP | 9 | $170 |
| Lundbeck LLC | 3 | $70 |
| PFIZER INC. | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
Products named: VRAYLAR, CAPLYTA, Ozempic, Rybelsus, REXULTI, FARXIGA, Auvelity, QULIPTA.
Industry payments across TN — which companies pay providers there.
